Avation Medical

My optimism about the growth potential of the Ohio Life Sciences industry was further validated after spending time with the Avation Medical team and its board. Exciting news as they celebrate the close of their Series C funding and the soft launch of the Vivally System, a revolutionary wearable #neuromodulation device to address overactive bladder (OAB) and incontinence issues affecting 42 MILLION Americans. Big things are happening in Ohio's #medtech scene! Congratulations to Jill Schiaparelli, MBA and the entire team!

We are thrilled to announce Avation Medical has received ISO 13485 certification, recognizing the highest quality standards for Avation Medical’s Quality Management System and certifying commitment to maintaining high standards in the design, production, and servicing of medical devices, including Avation’s groundbreaking Vivally® System. "The ISO certification underscores our commitment to delivering the Vivally System under the highest quality standards," said Dr. Manish Vaishya, Chief Technology Officer and Co-founder of Avation Medical. "This milestone marks an important step as we expand our reach internationally, bringing our transformative solutions to more patients worldwide." Thank you to the Avation Medical team members who contributed to this significant recognition. Avation is proud to be at the forefront of digital health and neuromodulation, empowering patients and healthcare providers with innovative, effective, and the highest quality solutions. Visit our website to read the full press release: https://lnkd.in/gdjZ4RhK

The Avation Medical team extends a warm welcome to Jennifer Estep, who joins Avation Medical as Vice President of Product Marketing & Customer Care. Jennifer brings more than a decade of medtech and pharmaceutical experience successfully bringing best-in-class solutions to market to benefit patients. Driven by her passion to advance world-class medtech innovation to benefit patients in need, Jennifer brings experience successfully commercializing a first-in-class combination product, building high-impact teams, communicating strategic life-improving innovations, and delivering solutions through internal and external collaborative partnerships. We are excited for Jennifer’s expertise in bringing the Vivally System to patients. Welcome to the Avation Medical team, Jennifer! Visit our website to read the full Press Release: https://lnkd.in/gdw8F5jq

Overactive bladder (OAB) is a chronic condition impacting the health and quality of life for 46 million people in the U.S.. But now there’s a new solution. A multi-center study published in Urology confirms the efficacy and safety of Avation® Medical’s non-invasive Vivally® System for symptoms of OAB. Here’s more: https://lnkd.in/gZxsXS7z

This Memorial Day, and every day, we honor the sacrifice and service of all those who are serving and have served. Thank you.

The MedTech Breakthrough Award for Healthcare Wearables Innovation goes to….the Vivally® System! The MedTech Breakthrough Award program recognizes the world’s most outstanding digital health and medical technology products, services, and companies. Vivally® was selected last year from more than 4,000 nominations from the largest and most innovative medical device companies in the world. Read more on our award-winning technology and how it can help transform patients’ lives: https://lnkd.in/ezZMpYZ3

Introducing the Vivally® System, the first FDA-cleared, closed-loop, at-home neuromodulation therapy for urinary incontinence and urgency from overactive bladder (OAB). 100% of OAB patients presented with Vivally® wanted to try this non-invasive, at-home therapy that helps them live life without disruption from frequent trips to the bathroom.. https://lnkd.in/gDFdt2t9

Medical Device News Magazine asked our own Jill Schiaparelli, MBA to share her story. Learn more about the vision to breakthrough chronic bladder control issues with a brand new way of safely and effectively treating overactive bladder: https://lnkd.in/gf3a9sFH

84% of people with overactive bladder experienced symptom relief using The Vivally® System in a multi-center clinical trial. Vivally® is: - Simple for patient activation and prescription. - Objective confirmation of nerve activation with patented closed-loop algorithm - Treatment and outcome visibility - Therapy personalization and dosing flexibility Clinicians — here’s more about the clinically proven, drug-free, non-invasive therapy breakthrough https://avation.com/news/

A patient-friendly safe and effective treatment for bladder control – with positive clinical outcomes. A multi-center study published on the cover of Urology - The Gold Journal confirms the efficacy and safety of Avation® Medical’s non-invasive Vivally® System for urinary incontinence and urgency caused by overactive bladder. Participants experienced significant reductions in symptoms, for a year, with this convenient, easy-to-use, at-home treatment. https://lnkd.in/gZxsXS7z